Former Associate Production Director and Research & Development Manager, Red Cross Central Fractionation Department, Belgium.
Ruth Laub is an independent consultant specialising in plasma derivative production and safety. She has twenty years experience as Associate Production Director and Research & Development Manager at the Red Cross Central Fractionation Department, Belgium. There she developed an original, semi-automated FVIII purification chain to produce VIII SD concentrates from cryoprecipitate. She holds a PhD from the Free University of Brussels and her research, at the de Duve Institute, Brussels (Catholic University of Leuven) involved neutral proteases, ferritin and siderophores. She focused later on FVIII epitopes, autoantibodies and their inhibitors, specific immunoglobulins, pollutant and virus removal from plasma derivatives, and virus inactivation techniques. She has served on the Board of Directors of Fonds de Biotechnologie – Biotechnologie Fonds, BIO.BE (Essencia), and Belgian Biotechnology Association. She has been a member of the International Society of Blood Transfusion, and the World Health Organisation International Working Group on Standardisation of Gene Amplification Technologies for the Virological Testing of Blood Products (SoGAT).
